Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis

doi:10.1016/S0016-5085(96)70026-4

Gastroenterology

Volume 111, Issue 6, December 1996, Pages 1627-1632

https://doi.org/10.1016/S0016-5085(96)70026-4 Get rights and content

Abstract

BACKGROUND & AIMS: Previous studies have shown that nitric oxide synthesis inhibition corrects the hyporesponsiveness to vasoconstrictors present in the mesenteric vascular bed of portal- hypertensive rats. The origin of this elevated NO production, whether endothelial or muscular, is unknown. The aim of this study was to evaluate the role of vascular endothelium in the hyporesponsiveness to methoxamine (MTX) in the mesenteric vascular bed of portal vein-ligated (PVL) and cirrhotic rats. METHODS: Endothelial denudation was achieved using a combined treatment of cholic acid and distilled water. RESULTS: Compared with the respective control groups, PVL rats showed a reduced vascular response to MTX. Similar results were obtained in cirrhotic animals. The presence of ascites was associated with a more severe reduction in the response to MTX. Removal of the endothelium completely corrected the vascular hyporesponsiveness of PVL, cirrhotic nonascitic, and ascitic animals. In these experiments, acetylcholine-mediated vasodilation was practically absent whereas that of sodium nitroprusside was potentiated, which indicates a successful elimination of the endothelium and the preservation of smooth muscle function. Immunostaining for NO synthase isoforms revealed the presence of endothelial NO synthase protein in healthy and PVL rats exclusively in the endothelium. CONCLUSIONS: The mesenteric vascular hyporesponsiveness to MTX present in these models of liver diseases and portal hypertension is solely due to endothelium-dependent factors. (Gastroenterology 1996 Dec;111(6):1627-32)

References (0)

Cited by (75)

Prostacyclin decreases splanchnic vascular contractility in cirrhotic rats
2014, Hepatobiliary and Pancreatic Diseases International
Prostacyclin has been shown to increase portal hypertension, but the mechanism is unclear. This study aimed to investigate whether the overproduction of prostacyclin (PGI₂) in cirrhosis participates in the splanchnic vascular hyporesponsiveness to vasoconstrictors in cirrhotic rats.
Cirrhotic model was created by subcutaneous injection of 60% carbon tetrachloride (CCl₄) corn oil solution combined with intermittent drinking of 5% alcohol, and age-matched rats served as controls. The isolated third-generation mesenteric arterioles were used to examine the contractile response to norepinephrine. The changes in vascular diameter were observed under a microscope imaging device. The plasma concentration of 6-ketone-prostaglandin F_1α (6-keto-PGF_1α, a stable metabolite of PGI₂) was tested via enzyme immunoassays and the expression of cyclooxygenase in mesenteric arteries was detected by Western blotting.
In parallel with the increase of plasma 6-keto-PGF_1α, the contractile response of arterioles from cirrhotic rats to norepinephrine was significantly impaired compared with that from controls. Inhibition of PGI₂ or protein kinase A with indomethacin or Rp-adenosine 3′, 5′-cyclic monophosphothioate (Rp-cAMPS) partially reversed the vascular hypo-contractile response to norepinephrine in arterioles from cirrhotic rats. Indomethacin significantly decreased the plasma 6-keto-PGF_1α. Furthermore, indomethacin significantly attenuated the effect of Rp-cAMPS on arterioles from cirrhotic rats. COX-1 expression was up-regulated in mesenteric arteries from cirrhotic rats, whereas COX-2 was not detectable in the mesenteric arteries from both cirrhotic and control rats.
Enhanced COX-1 expression in cirrhotic rats resulted in elevated PGI₂ production which partially contributed to the splanchnic vascular hyporesponsiveness to a vasoconstrictor via the protein kinase A pathway.
Portal Hypertension and Gastrointestinal Bleeding
2010, Sleisenger and Fordtran’s Gastrointestinal and Liver Disease- 2 Volume Set: Pathophysiology, Diagnosis, Management, Expert Consult Premium Edition - Enhanced Online Features and Print
Portal Hypertension and Variceal Hemorrhage
2008, Medical Clinics of North America
Citation Excerpt :
Cirrhosis is associated with a hyperdynamic circulatory state that is characterized by peripheral and splanchnic vasodilation, reduced mean arterial pressure, and increased cardiac output. NO-mediated splanchnic vasodilatation [8–16] produces an increase in inflow of systemic blood into the portal circulation, which causes an increase in portal pressure [17]. Portal pressure is most commonly determined by the hepatic vein pressure gradient (HVPG), which is the difference between the wedged hepatic venous pressure (reflecting the hepatic sinusoidal pressure) and free hepatic vein pressure [18,19].
Portal hypertension, a major hallmark of cirrhosis, is defined as a portal pressure gradient exceeding 5 mm Hg. In portal hypertension, porto-systemic collaterals decompress the portal circulation and give rise to varices. Successful management of portal hypertension and its complications requires knowledge of the underlying pathophysiology, the pertinent anatomy, and the natural history of the collateral circulation, particularly the gastroesophageal varices.
Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis
2008, Molecular Aspects of Medicine
Portal hypertension is primarily caused by the increase in resistance to portal outflow and secondly by an increase in splanchnic blood flow, which worsens and maintains the increased portal pressure. Increased portal inflow plays a role in the hyperdynamic circulatory syndrome, a characteristic feature of portal hypertensive patients. Almost all the known vasoactive systems/substances are activated in portal hypertension, but most authors stress the pathogenetic role of endothelial factors, such as COX-derivatives, nitric oxide, carbon monoxide. Endothelial dysfunction is differentially involved in different vascular beds and consists in alteration in response both to vasodilators and to vasoconstrictors. Understanding the pathogenesis of portal hypertension could be of great utility in preventing and curing the complications of portal hypertension, such as esophageal varices, hepatic encephalopathy, ascites.
Nitric oxide and portal hypertension: Interface of vasoreactivity and angiogenesis
2006, Journal of Hepatology
Citation Excerpt :
In contrast to diminished intrahepatic bioavailability of NO, the splanchnic (and systemic) circulation experiences a relative excess in regional NO generation [7]. This increased production is largely endothelium and eNOS dependent [35–37]. However, iNOS and nNOS have been implicated as well and studies in NOS isoform gene deletion mice have not fully clarified the matter [38–41].
Reduced capacitative calcium entry in the mesenteric vascular bed of bile duct-ligated rats
2005, European Journal of Pharmacology
In this work, we analyzed the interaction of nitric oxide (NO) with some of the mechanisms known to regulate intracellular calcium levels in order to gain insight into the mechanisms responsible for the reduced vascular pressor response to vasoconstrictors observed in an experimental model of liver cirrhosis. Specifically, we hypothesized that the entry of calcium through capacitative channels is defective in this model. The experiments were performed with isolated, Krebs-perfused and de-endothelialized mesenteric arterial bed of rats with bile duct ligation (4 weeks) and their controls. Pretreatment with thapsigargin to inhibit calcium uptake into sarcoplasmic reticulum potentiated the pressor responses to methoxamine, but the response of the cirrhotic vessels was significantly lower than that of the controls. Under the same conditions, perfusion of the mesenteries with zero calcium-Krebs resulted in lower pressor responses to methoxamine, especially in the mesenteries of the bile duct-ligated rats. To specifically analyze the entry of calcium through store-operated calcium channels, the pressor response to the addition of calcium was studied in mesenteries perfused with zero calcium-Krebs and in the presence of thapsigargin. Again, the response of the cirrhotic mesenteric beds was significantly lower than that of the control vessels. Under all these experimental conditions, the differences between control and cirrhotic responses were abolished by pretreatment with the NO synthesis inhibitor N^w-nitro-l-arginine (NNA). These results indicate that, in the mesenteric bed of bile duct-ligated rats, an excess of nitric oxide interferes with the release of calcium from thapsigargin-sensitive internal stores and also reduces the capacitative entry of calcium into vascular muscular cells induced by the depletion of calcium from internal stores. This mechanism may have an important role in the reduced pressor response observed in the mesenteric vascular bed in cirrhosis.

View all citing articles on Scopus

View full text